MoneyWorks4Me

Trident Lifeline acquires additional stake in Trident Mediquip

02 Jan 2026 Evaluate

Trident Lifeline has made further Investment by acquiring an additional equity stake of 9.04% of Trident Mediquip (TML), a subsidiary company from existing shareholders of the Company. Pursuant to the above, the shareholding of the company in TML has increased from 51% to 60.04%. Cost of acquisition is around Rs 4.42 crore.

Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market.


Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..